Monographie - Fosaprepitant dimeglumine

Son güncelleme :
28/04/2024

Fosaprepitant dimeglumine

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Emend	Amerika Birleşik Devletleri, Kanada
Fosaprepitant
IV-Emend	Avusturya, Büyük Britanya, İsviçre, Japonya, Norveç

Kaynaklar : Fosaprepitant dimeglumine

	Tip	Yayın
2295	Laboratuar	Fosaprepitant (Emend®) - Summary of Product Characteristics Merck Sharp Dohme 2013
3459	Dergi	Sun S, Schaller J, Placek J, Duersch B. Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids. Cancer Chemother Pharmacol 2013 ; 72: 509-513.

Mentions Légales